CancerVax Corporation
Quick facts
Phase 3 pipeline
- CancerVax vaccine (CANVAXIN) · Oncology
CANVAXIN is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: